Louisiana Funds — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Esperancepharmaesperancepharma.comJun 2019
Esperance Pharmaceuticals develops targeted anticancer drugs designed to bind specific receptors on cancer cell surfaces and selectively kill cancer cells, including chemotherapy-resistant cells, while sparing normal cells.
BiotechHealthtechHouston, US
Hector Alila(Executive Officer, Director)Ross Barrett(Director)Joseph Lovett(Director)Peter Hoang(Director)Sonia Deggs(Executive Officer)Carola Leuschner(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.